GlassScriptPhysician profile
Kara Morton
NPI 1639524234
$621.93
in general payments reported to CMS, 2019-2025
13 companies · $89.59 in 2025
The $89.59 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.36 · 2022: $113 · 2023: $168 · 2024: $167 · 2025: $89.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $168.63 | 2023-2024 | |
| Pfizer INC. | $92.91 | 2021-2022 | |
| Hologic Sales and Service, LLC | $71.66 | 2021-2024 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $52.76 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $49.24 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Novo Nordisk INC | $40.34 | 2024 | Saxenda, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $34.00 | 2022-2024 | |
| Biogen, INC. | $27.27 | 2025 | Zurzuvae |
| Coloplast Corp | $23.46 | 2023 | Saffron |
| Millicent US INC | $20.95 | 2025 | Femlyv |
| Agile Therapeutics, INC. | $20.83 | 2021 | |
| Avion Pharmaceuticals | $11.42 | 2021 | |
| Mayne Pharma Commercial LLC | $8.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.